UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run

UroGen’s Chief Medical Officer sold $400,000 in company stock after shares surged 191%, according to an SEC Form 4 filing. Mark Schoenberg sold 10,000 ordinary shares of UroGen Pharma Ltd. (NASDAQ: URGN) on July 9, 2026, for a total value of $400,000. The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on August 15, 2025, and it represents the final trade of that plan’s scheduled sales. Schoenberg still directly holds 119,763 ordinary shares. At the time, UroGen’s market capitalization was $2.0 billion, and the stock closed at $40.23 on July 9, 2026. The company reported trailing 12-month revenue of $140.5 million and a net loss of $133.2 million.